Search
Sangamo Therapeutics Inc
SGMOAdd to Watchlist
0.178USD
0.0000.00%
Close 07/01, 16:00（ET）Quotes delayed by 15 min
22.33MMarket Cap
LossP/E TTM
Sangamo Therapeutics Inc Earnings Date
Period
FY2025 Earnings Date
Revenue(YoY)
39.55M
-31.57%
EPS(YoY)
-0.44
9.65%
Analyst Rating
BUY
2026-07-01
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of Sangamo Therapeutics Inc?
According to Sangamo Therapeutics Inc's FY2025 earnings report, its total revenue reached 39.55M, with a year-on-year change of -31.57.
What are the current assets of Sangamo Therapeutics Inc?
According to Sangamo Therapeutics Inc's FY2025 earnings report, its current assets were 35.83M, with a year-on-year change of -30.68.
What are the total assets of Sangamo Therapeutics Inc?
According to Sangamo Therapeutics Inc's FY2025 earnings report, its total assets of Sangamo Therapeutics Inc were 59.74M, with a year-on-year change of -41.22.
What are the total liabilities of Sangamo Therapeutics Inc?
According to Sangamo Therapeutics Inc's FY2025 earnings report, its total liabilities of Sangamo Therapeutics Inc were 74.01M, with a year-on-year change of -6.15.
What is the total equity of Sangamo Therapeutics Inc?
According to Sangamo Therapeutics Inc's FY2025 earnings report, its total equity of Sangamo Therapeutics Inc was -14.27M, with a year-on-year change of -162.66.
What is the net investment of Sangamo Therapeutics Inc?
According to Sangamo Therapeutics Inc's FY2025 earnings report, its net investment of Sangamo Therapeutics Inc was -102.00K, with a year-on-year change of -100.27.
What is the net financing of Sangamo Therapeutics Inc?
According to Sangamo Therapeutics Inc's FY2025 earnings report, its net financing of Sangamo Therapeutics Inc was 70.75M, with a year-on-year change of 149.32.
What is the Earnings Per Share (EPS) of Sangamo Therapeutics Inc?
According to Sangamo Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -0.44, with a year-on-year change of 9.65.
What is the net margin of Sangamo Therapeutics Inc?
According to Sangamo Therapeutics Inc's FY2025 earnings report, its net profit margin was -310.81, with a year-on-year change of -83.43.
What is the Return on Equity (ROE) of Sangamo Therapeutics Inc?
According to Sangamo Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -2891.84, with a year-on-year change of -1459.83.
What is the Return on Assets (ROA) of Sangamo Therapeutics Inc?
According to Sangamo Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -152.35, with a year-on-year change of -107.63.
What is the operating profit of Sangamo Therapeutics Inc?
According to Sangamo Therapeutics Inc's FY2025 earnings report, its operating profit was -108.00M, with a year-on-year change of -10.04.